SPBC1685.05 Antibody

What is SPBC1685.05 antibody and what cellular mechanisms does it help investigate?

SPBC1685.05 antibody (product code CSB-PA526697XA01SXV) recognizes a specific protein (UniProt ID: O74325) in Schizosaccharomyces pombe (fission yeast strain 972/ATCC 24843) . This antibody serves as a key tool for investigating cellular mechanisms in this model organism, which is widely used for studying cell cycle regulation, DNA damage response, and gene expression. The protein targeted by this antibody may play roles in cellular processes that can be elucidated through immunological techniques. When designing experiments with this antibody, researchers should consider its specificity for fission yeast proteins and potential cross-reactivity with related proteins in other species.

To effectively utilize this antibody in research, start with validation experiments such as Western blotting to confirm specificity before proceeding to more complex applications like immunoprecipitation or immunofluorescence. This approach ensures reliable results and minimizes artifacts in subsequent experiments.

What are the recommended experimental conditions for optimal SPBC1685.05 antibody performance?

For optimal performance of SPBC1685.05 antibody in experimental settings, several methodological considerations are essential. Begin with proper sample preparation, including gentle cell lysis methods that preserve protein structure while maximizing extraction efficiency from fission yeast cells. A buffer system containing protease inhibitors is crucial to prevent degradation of the target protein during extraction.

For immunoblotting applications, the following conditions typically yield optimal results: dilution factors between 1:500 to 1:2000 in 5% non-fat milk or BSA in TBST, incubation overnight at 4°C, and thorough washing steps to minimize background. For immunofluorescence or immunohistochemistry, fixation method significantly impacts antibody performance—paraformaldehyde fixation (4%, 15-20 minutes) often works well for preserving epitope structure in yeast cells. Antigen retrieval methods might be necessary if formaldehyde fixation creates cross-links that mask the epitope. Always perform parallel negative controls to assess non-specific binding and optimize blocking conditions accordingly.

How does SPBC1685.05 antibody compare with other fission yeast protein detection methods?

SPBC1685.05 antibody offers several advantages over alternative detection methods for fission yeast proteins. Unlike genetic tagging approaches, antibodies allow detection of native, unmodified proteins without potential functional interference from fusion tags . This is particularly valuable when studying proteins where C- or N-terminal modifications might disrupt localization or interaction patterns.

What validation steps should be performed before using SPBC1685.05 antibody in critical experiments?

Comprehensive validation of SPBC1685.05 antibody is essential before conducting critical experiments. Begin with Western blot analysis using both wild-type fission yeast extracts and extracts from cells where the target gene has been deleted or downregulated, which serves as the gold standard for specificity confirmation. A single band of the expected molecular weight in wild-type samples that disappears in knockout samples strongly indicates antibody specificity.

For immunofluorescence applications, perform parallel staining of wild-type and knockout strains, examining colocalization with known markers of relevant cellular compartments. Additionally, conduct peptide competition assays where the antibody is pre-incubated with excess purified antigen or immunizing peptide before application to samples—specific signals should be significantly reduced or eliminated . Cross-reactivity testing against related proteins, particularly if studying conserved protein families, is also recommended. Document batch-to-batch variation through consistent validation protocols each time a new lot is received, maintaining detailed records of optimization parameters.

How can researchers troubleshoot weak or non-specific signals when using SPBC1685.05 antibody?

When encountering weak signals with SPBC1685.05 antibody, methodically evaluate and optimize several parameters. First, assess protein extraction efficiency—fission yeast cells have tough cell walls requiring optimized lysis protocols, such as mechanical disruption combined with enzymatic methods. Experiment with different extraction buffers (RIPA vs. NP-40 vs. Triton X-100) as buffer composition affects protein solubility and epitope accessibility.

For non-specific signals, implement more stringent washing protocols with increased salt concentration (up to 500mM NaCl) or mild detergents (0.1-0.3% Tween-20) in wash buffers. Optimize blocking solutions by comparing BSA, non-fat milk, and commercial blocking reagents at different concentrations (3-5%). Consider titrating antibody concentrations systematically (1:100 to 1:5000) to identify the optimal signal-to-noise ratio. If background persists, pre-absorb the antibody against fixed cells lacking the target protein.

What are the optimal fixation and permeabilization methods when using SPBC1685.05 antibody for immunofluorescence in fission yeast?

Optimizing fixation and permeabilization methods is critical for successful immunofluorescence with SPBC1685.05 antibody in fission yeast. For fixation, compare 4% paraformaldehyde (15-20 minutes, room temperature), methanol (-20°C, 6-10 minutes), or a combination approach of brief paraformaldehyde fixation followed by methanol treatment. The optimal method depends on the specific cellular location and biochemical properties of the SPBC1685.05 target protein.

For cell wall digestion and permeabilization, enzymatic approaches using Zymolyase (0.5-1 mg/ml, 30-60 minutes at 30°C) or Lysing Enzymes from Trichoderma harzianum are effective. Follow with gentle permeabilization using 0.1-0.5% Triton X-100 or 0.05% SDS for cytoplasmic proteins, while methanol fixation alone may be sufficient for nuclear proteins. To preserve membranes while allowing antibody access, digitonin (10-50 μg/ml) provides selective permeabilization of plasma membranes while preserving internal membranes.

When optimizing, prepare a matrix experiment testing different fixation and permeabilization combinations with appropriate controls, including both negative controls (secondary antibody only) and positive controls (antibodies against well-characterized proteins with similar subcellular localization). Document cellular morphology preservation for each method, as aggressive permeabilization can disrupt structural integrity and create artifacts.

How can SPBC1685.05 antibody be effectively used in immunoprecipitation experiments to identify protein interaction partners?

Implementing effective immunoprecipitation (IP) protocols with SPBC1685.05 antibody requires careful optimization to identify genuine protein interaction partners. Begin by evaluating different lysis conditions that preserve protein-protein interactions—typically mild non-ionic detergents (0.5-1% NP-40 or 0.5% Triton X-100) are preferred over harsh ionic detergents like SDS that disrupt interactions. Include protease and phosphatase inhibitor cocktails to prevent degradation and maintain post-translational modifications.

For antibody coupling, compare different approaches including direct antibody addition followed by Protein A/G beads, pre-coupling antibodies to beads before sample addition, and covalent cross-linking of antibodies to beads using dimethyl pimelimidate to prevent antibody contamination in the final sample . Optimize antibody concentration through titration experiments (typically 1-5 μg per IP reaction) to maximize target protein capture while minimizing non-specific binding.

Control experiments are crucial for result interpretation: include a non-related antibody of the same isotype as a negative control and perform parallel IPs from cell lines lacking the target protein. For interaction partner identification, combine with mass spectrometry analysis, but implement statistical approaches to distinguish genuine interactors from background contaminants. This might include quantitative proteomics approaches like SILAC or TMT labeling that allow direct comparison between experimental and control samples.

What strategies can be employed to study post-translational modifications of the SPBC1685.05 target protein?

Investigating post-translational modifications (PTMs) of the SPBC1685.05 target protein requires integrated approaches combining immunological techniques with advanced analytical methods. Begin by immunoprecipitating the target protein using validated SPBC1685.05 antibody protocols, followed by targeted Western blotting with modification-specific antibodies (phospho-, acetyl-, ubiquitin-, or SUMO-specific) to screen for potential modifications.

For comprehensive PTM profiling, immunoprecipitate the target protein and analyze by mass spectrometry. Implement enrichment strategies specific to the PTM of interest—phosphopeptide enrichment using titanium dioxide or IMAC for phosphorylation studies, or ubiquitin remnant antibodies for ubiquitination analysis . When designing these experiments, consider stress conditions or cell cycle stages that might regulate the modifications of interest.

To determine the biological significance of identified PTMs, site-directed mutagenesis of modified residues combined with phenotypic analysis provides functional insights. Develop phospho-specific antibodies for important sites to track modification dynamics under different conditions. Temporal resolution can be enhanced through synchronized cell populations or induced expression systems. For challenging modifications with low stoichiometry, consider proximity labeling approaches (BioID or TurboID) coupled with the target protein to identify transient interaction partners that might be responsible for adding or removing modifications.

How can SPBC1685.05 antibody be utilized in ChIP-seq experiments to study protein-DNA interactions?

Adapting SPBC1685.05 antibody for Chromatin Immunoprecipitation followed by sequencing (ChIP-seq) requires specific optimization for the fission yeast system. Begin with crosslinking optimization—typically 1% formaldehyde for 10-15 minutes, but titrate both concentration (0.5-3%) and time (5-30 minutes) to balance efficient crosslinking with epitope preservation. For fission yeast, cell wall digestion prior to or during lysis is essential—combine enzymatic treatment (Zymolyase) with mechanical disruption.

Chromatin fragmentation requires careful optimization; compare sonication parameters (amplitude, cycle number, duration) with enzymatic fragmentation using MNase. Target fragment sizes of 200-500bp provide optimal resolution for most applications. Perform IP optimization with different antibody amounts (2-10μg) and incubation conditions (4°C overnight vs. room temperature for shorter periods). Include appropriate controls: input samples (pre-IP chromatin), mock IP (no antibody or isotype control), and ideally, IP from strains lacking the target protein.

For bioinformatic analysis, implement quality control metrics including fragment size distribution, library complexity assessment, and cross-correlation analysis. Distinguish genuine binding sites from artifacts through statistical approaches comparing experimental samples to appropriate controls. Validate key binding sites through orthogonal methods such as ChIP-qPCR. For mechanistic insights, correlate binding patterns with gene expression data, histone modifications, or other chromatin features through integrated genomic analyses.

How should researchers interpret unexpected subcellular localization patterns observed with SPBC1685.05 antibody?

Consider biological conditions that might influence localization—stress responses, cell cycle stages, or nutritional status can dramatically alter protein distribution. Perform time-course experiments to capture dynamic localization changes and co-staining with markers for different subcellular compartments to precisely define the observed pattern. If the unexpected localization suggests potential moonlighting functions, design focused experiments to test this hypothesis, such as compartment-specific interaction studies or functional assays.

Technical considerations must also be evaluated—fixation artifacts can significantly impact apparent localization. Compare multiple fixation protocols (paraformaldehyde, methanol, glutaraldehyde) and assess whether the pattern remains consistent. Cross-reactivity with related proteins might explain unexpected patterns, which can be addressed through parallel staining of knockout strains or peptide competition assays. Document all validation steps thoroughly to support publication of novel localization findings.

What statistical approaches are recommended for analyzing quantitative data generated using SPBC1685.05 antibody?

Robust statistical analysis of quantitative data generated with SPBC1685.05 antibody requires thoughtful experimental design and appropriate analytical methods. For experimental design, implement biological replicates (different cell cultures) rather than just technical replicates (repeated measurements of the same sample) to account for biological variability. A minimum of three independent biological replicates is recommended, with power analysis guiding sample size for detecting expected effect sizes.

Statistical analysis should match the experimental design—paired t-tests for before/after comparisons within the same samples, ANOVA with appropriate post-hoc tests for multi-group comparisons, or non-parametric alternatives when normality assumptions are violated. When analyzing correlations between protein levels and phenotypic outcomes, consider regression approaches that account for potential confounding variables. For all analyses, report effect sizes alongside p-values to communicate biological significance, not just statistical significance.

How can researchers address conflicting results between SPBC1685.05 antibody data and other experimental approaches?

Addressing conflicting results between SPBC1685.05 antibody-based experiments and alternative approaches requires systematic investigation rather than dismissing either dataset. Begin by evaluating the methodological strengths and limitations of each approach—antibody-based methods excel at detecting native proteins but may have specificity issues, while tagged protein approaches avoid specificity concerns but may alter protein function or localization.

Conduct reconciliation experiments specifically designed to address the discrepancy. For conflicts in protein levels, compare antibody detection with absolute quantification methods like selected reaction monitoring mass spectrometry or quantitative fluorescence standards. For localization conflicts, perform parallel analysis on the same cell population using both approaches and evaluate whether differences might be attributable to fixation effects versus live-cell imaging artifacts.

What cell synchronization methods are compatible with subsequent SPBC1685.05 antibody-based analysis?

For cell cycle studies using SPBC1685.05 antibody in fission yeast, various synchronization methods offer different advantages and limitations. Temperature-sensitive cdc mutants (particularly cdc25-22) provide tight synchronization at G2/M transition when shifted to restrictive temperature (36°C for 4 hours) followed by release to permissive temperature (25°C). This method yields high synchrony but introduces heat stress that may affect protein regulation or localization.

Alternatively, metabolic synchronization using nitrogen starvation induces G1 arrest, with cells progressing synchronously through the cell cycle upon nitrogen readdition. This approach avoids temperature manipulation but may alter protein expression patterns due to nutritional stress responses. For less invasive synchronization, size selection through centrifugal elutriation separates cells based on size (corresponding to cell cycle stage) without introducing artificial blocks, though it provides lower synchrony levels.

When designing experiments, evaluate whether the synchronization method itself might impact the biological process under study. Document synchronization efficiency through parallel flow cytometry or microscopic analysis of septation index. For time-course studies, collect samples at appropriate intervals (typically 20-minute intervals for preliminary studies, refined based on initial results) and process all samples simultaneously for antibody-based detection to minimize technical variability.

How should researchers approach epitope accessibility challenges in the thick cell walls of fission yeast?

The robust cell wall of Schizosaccharomyces pombe presents unique challenges for antibody-based studies that require methodological adaptations. For immunofluorescence applications, implement a two-stage permeabilization approach—first enzymatically digest the cell wall using Zymolyase (0.5-1 mg/ml) or Lysing Enzymes from Trichoderma harzianum (5 mg/ml) for 30-60 minutes at 30°C, monitoring protoplast formation microscopically. Follow with membrane permeabilization using detergents like Triton X-100 (0.1-0.5%) or SDS (0.05%).

Cell fixation timing is critical—pre-fixation before enzymatic digestion preserves structure but may reduce digestion efficiency and epitope accessibility, while post-digestion fixation improves antibody access but may compromise structural integrity. Compare both approaches to determine optimal protocols for specific applications. For thick-section immunohistochemistry, antigen retrieval methods using microwave heating in citrate buffer (pH 6.0) can enhance epitope accessibility.

For biochemical applications like co-immunoprecipitation, mechanical disruption methods (glass bead beating or high-pressure homogenization) combined with enzymatic pre-treatment yield more complete protein extraction. Optimize lysis buffer composition to balance efficient extraction with preservation of protein-protein interactions. Monitor extraction efficiency through microscopic examination of cell ghosts and Western blotting for cytoplasmic, nuclear, and membrane marker proteins.

What emerging technologies might enhance the research applications of SPBC1685.05 antibody?

Several emerging technologies promise to expand the utility of SPBC1685.05 antibody in fission yeast research. Proximity labeling methods like BioID or TurboID, when combined with antibody-based purification approaches, can reveal transient or weak interaction partners that traditional co-immunoprecipitation might miss. By fusing biotin ligase to the target protein, researchers can biotinylate proximal proteins, which are then purified using streptavidin and identified by mass spectrometry, complementing traditional antibody-based interaction studies.

Single-cell proteomics approaches are advancing rapidly and may soon allow antibody-based protein quantification at single-cell resolution in yeast populations. This would reveal cell-to-cell heterogeneity in protein expression and modification states that bulk analyses obscure. Super-resolution microscopy techniques like STORM, PALM, or expansion microscopy can be adapted for yeast cells to provide nanoscale resolution of protein localization patterns when used with validated antibodies .

CRISPR-based tagging approaches allow endogenous proteins to be tagged with split-fluorescent proteins or epitope tags, creating systems where antibody detection can be precisely controlled and validated. This offers new opportunities for multiplexed detection strategies and orthogonal validation of antibody specificity. As these technologies mature, integration with computational approaches like machine learning for image analysis will further enhance the quantitative insights gained from antibody-based studies.

How can researchers contribute to improving community resources for SPBC1685.05 antibody validation?

Researchers can significantly advance the field by contributing to community resources for SPBC1685.05 antibody validation through several practical approaches. First, establish and share detailed validation protocols that extend beyond manufacturer recommendations, including systematic testing across multiple applications and experimental conditions. Document these in protocol repositories like protocols.io or through methods papers in appropriate journals.

Contributing validation data to antibody validation databases like Antibodypedia or the Antibody Registry enhances collective knowledge about reagent performance across different laboratories and applications. When publishing research using this antibody, include comprehensive supplementary materials detailing validation steps, optimization parameters, and batch information to enable reproduction.

For advanced users, developing standardized positive and negative control samples (such as recombinant protein standards or knockout cell extracts) and making these available to the community through repositories or collaboration networks can accelerate validation efforts. Participation in multi-laboratory standardization initiatives or ring trials where the same antibody is tested across different labs using standardized protocols identifies sources of variability and establishes best practices.